Quarterly report · Q2
7681.TEDINET S100TEYE
Period2023-10-01 → 2024-03-31
Filed2024-05-15
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥12.2bn | 2023-10-01 → 2024-03-31 | Cons. | Net sales |
| Revenue | ¥26.6bn | 2022-10-01 → 2023-09-30 | Cons. | Net sales (5-year summary) |
| Revenue | ¥11.7bn | 2022-10-01 → 2023-03-31 | Cons. | Net sales |
| Operating income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Operating income |
| Operating income | ¥263m | 2022-10-01 → 2023-03-31 | Cons. | Operating income |
| Ordinary income | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Ordinary income |
| Ordinary income | ¥432m | 2022-10-01 → 2023-09-30 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Ordinary income |
| Profit before tax | ¥358m | 2023-10-01 → 2024-03-31 | Cons. | Income before income taxes |
| Profit before tax | ¥249m | 2022-10-01 → 2023-03-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥221m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥271m | 2022-10-01 → 2023-09-30 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥144m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥229m | 2023-10-01 → 2024-03-31 | Cons. | Profit loss |
| Net income | ¥154m | 2022-10-01 → 2023-03-31 | Cons. | Profit loss |
| Total assets | ¥13.5bn | at 2024-03-31 | Cons. | Assets |
| Total assets | ¥14.7bn | at 2023-09-30 | Cons. | Assets |
| Total assets | ¥15.3bn | at 2023-03-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥7.7bn | at 2024-03-31 | Cons. | Liabilities |
| Total liabilities | ¥9.0bn | at 2023-09-30 | Cons. | Liabilities |
| Net assets / equity | ¥5.9bn | at 2024-03-31 | Cons. | Net assets |
| Net assets / equity | ¥5.7bn | at 2023-09-30 | Cons. | Net assets |
| Net assets / equity | ¥5.6bn | at 2023-03-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥5.9bn | at 2024-03-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥5.5bn | at 2023-09-30 | Cons. | Cash and deposits |
| Cash & equivalents | ¥5.9bn | at 2024-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2023-09-30 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.1bn | at 2023-03-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥5.5bn | at 2022-09-30d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥521m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥342m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | −¥219m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | −¥23m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥82m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥55m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥100m | 2023-10-01 → 2024-03-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥202m | 2022-10-01 → 2023-09-30 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥118m | 2022-10-01 → 2023-03-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥112.46 | 2023-10-01 → 2024-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥71.45 | 2024-01-01 → 2024-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥138.37 | 2022-10-01 → 2023-09-30 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥73.31 | 2022-10-01 → 2023-03-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥85.68 | 2023-01-01 → 2023-03-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥111.78 | 2023-10-01 → 2024-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥137.52 | 2022-10-01 → 2023-09-30 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥73.09 | 2022-10-01 → 2023-03-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 42.2% | at 2024-03-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 37.9% | at 2023-09-30 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 35.4% | at 2023-03-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
Segments · 26
| Segment | Item | Period | Value |
|---|---|---|---|
| Reconciling Itemsreconciling | segment profit | 2023-10-01 → 2024-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥211m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥7m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥372m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥31m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2023-10-01 → 2024-03-31 | ¥11.6bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2023-10-01 → 2024-03-31 | ¥319m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2023-10-01 → 2024-03-31 | ¥12.2bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2023-10-01 → 2024-03-31 | ¥357m |
| Reconciling Itemsreconciling | segment profit | 2022-10-01 → 2023-03-31 | ¥1m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥205m |
| jpcrp040300-q2r_E34455-000Food Servicereportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥4m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥362m |
| jpcrp040300-q2r_E34455-000Remote Image Diagnosis Service Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥39m |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | revenue external | 2022-10-01 → 2023-03-31 | ¥11.1bn |
| jpcrp040300-q2r_E34455-000Total Medical Solution Businessreportable segment | segment profit | 2022-10-01 → 2023-03-31 | ¥219m |
| Total Of Reportable Segments And Otherssegment total | revenue | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | revenue external | 2022-10-01 → 2023-03-31 | ¥11.7bn |
| Total Of Reportable Segments And Otherssegment total | segment profit | 2022-10-01 → 2023-03-31 | ¥262m |
Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.
All source rows · 500
| Item | Context | Value | Unit |
|---|---|---|---|
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 218702000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 39092000 | JPY |
| Operating income | Prior1YTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 4325000 | JPY |
| Operating income | Prior1YTDDuration_TotalOfReportableSegmentsAndOthersMember | 262121000 | JPY |
| Operating income | Prior1YTDDuration_ReconcilingItemsMember | 1068000 | JPY |
| Operating income | Prior1YTDDuration | 263190000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11633398000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 372464000 | JPY |
| Revenues from external customers | CurrentYTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 210815000 | JPY |
| Revenues from external customers | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12216679000 | JPY |
| Revenues from external customers | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Revenues from external customers | CurrentYTDDuration | 12216679000 | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Transactions with other segments | CurrentYTDDuration | － | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 11633398000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 372464000 | JPY |
| Net sales | CurrentYTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 210815000 | JPY |
| Net sales | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 12216679000 | JPY |
| Net sales | CurrentYTDDuration_ReconcilingItemsMember | － | JPY |
| Net sales | CurrentYTDDuration | 12216679000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E34455-000TotalMedicalSolutionBusinessReportableSegmentMember | 318654000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E34455-000RemoteImageDiagnosisServiceBusinessReportableSegmentMember | 30901000 | JPY |
| Operating income | CurrentYTDDuration_jpcrp040300-q2r_E34455-000FoodServiceReportableSegmentMember | 7262000 | JPY |
| Operating income | CurrentYTDDuration_TotalOfReportableSegmentsAndOthersMember | 356818000 | JPY |
| Operating income | CurrentYTDDuration_ReconcilingItemsMember | 1180000 | JPY |
| Operating income | CurrentYTDDuration | 357998000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)近畿財務局長 | |
| Filing date cover page | FilingDateInstant | 2024-05-15 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第24期第２四半期(自 2024年１月１日 至 2024年３月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)株式会社レオクラン | |
| Company name in english cover page | FilingDateInstant | LEOCLAN Co.,Ltd. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 杉田 昭吾 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)大阪府摂津市千里丘２丁目４番26号 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | 06(6387)1554 | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)取締役管理本部長 筒井 照己 | |
| Nearest place of contact cover page | FilingDateInstant | Original text (Japanese)大阪府摂津市千里丘２丁目４番26号 | |
| Telephone number nearest place of contact cover page | FilingDateInstant | 06(6387)1554 | |
| Name of contact person nearest place of contact cover page | FilingDateInstant | Original text (Japanese)取締役管理本部長 筒井 照己 | |
| Place for public inspection cover page (text) | FilingDateInstant | Text · Plus | |
| Edinet code | FilingDateInstant | E34455 | |
| Fund code | FilingDateInstant | － | |
| Security code | FilingDateInstant | 76810 | |
| Filer name in japanese | FilingDateInstant | Original text (Japanese)株式会社レオクラン | |
| Filer name in english | FilingDateInstant | LEOCLAN Co.,Ltd. |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |